Cardiovascular (CV) disease is the leading cause of morbidity and mortality in the US and worldwide. Non-invasive imaging provides valuable information to assess differential diagnosis and to help formulate a management plan. Unfortunately, most existing training programs in CV imaging offer only fragmented and discipline-constrained training opportunities, and very few offer training that incorporates clinicl and translational research in imaging science. This is the first competing renewal application for Brigham and Women's Hospital noninvasive cardiovascular imaging T32 program. This program offers post-doctoral research training for individuals with an MD, or combined MD/PhD degrees, who have completed clinical training in cardiology, radiology, or cardiovascular imaging who are committed to pursuing an academic career in CV imaging science. Our objective is to provide a multidisciplinary research environment that integrates CV biology, pharmacology, and imaging technology, with which to train clinician-scientists in translational imaging science. All the fellws have presented their work at national meetings. In the first 3.5 years of this T32 grant, our trainees have authored 63 manuscripts (some currently under review) with more than 90% being original contributions. Importantly, those who completed training to date have obtained academic faculty positions and have already obtained or are actively pursuing independent funding opportunities, all strong indicators of program success. Our mentors are primarily comprised of cardiologists and radiologists, but also include faculty from Pulmonary Medicine, Pathology, Anesthesia, Endocrinology, and the Center for Systems Biology at MGH. All of the mentors have an extensive portfolio of collaborations. We offer research opportunities in seven primary areas of imaging research: (1) molecular imaging, (2) myocardial structure and function, (3) cell-based therapy, (4) genetics, (5) pulmonary hypertension, (6) vascular imaging, and (7) outcomes research. The proposed program supports 3 positions/year for two years of continued research training. With this renewal, we continue our primary goals of providing leadership in academic cardiovascular imaging and training future leaders in imaging science to improve outcomes in cardiovascular disease.

Public Health Relevance

The proposed competing application of our T32 training program is designed to train clinician-scientists in cardiovascular imaging to prepare them for successful and productive academic careers. The program offers mutli-disciplinary training in a broad and diverse spectrum of areas in cardiovascular medicine with relevance to imaging science. With this renewal, we continue our primary goals of providing leadership in academic cardiovascular imaging and training future leaders in imaging science to improve outcomes in cardiovascular disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL094301-09
Application #
9515653
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Huang, Li-Shin
Project Start
2010-07-01
Project End
2020-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
9
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
Vaduganathan, Muthiah; Qamar, Arman; Gupta, Ankur et al. (2018) Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials. Am J Med 131:575-577
Wu, Candace; Singh, Avinainder; Collins, Bradley et al. (2018) Causes of Troponin Elevation and Associated Mortality in Young Patients. Am J Med 131:284-292.e1
Kalra, Rajat; Arora, Garima; Patel, Nirav et al. (2018) Targeted Temperature Management After Cardiac Arrest: Systematic Review and Meta-analyses. Anesth Analg 126:867-875
Fujikura, Kana; Peltzer, Bradley; Tiwari, Nidhish et al. (2018) Reduced global longitudinal strain is associated with increased risk of cardiovascular events or death after kidney transplant. Int J Cardiol 272:323-328
Singh, Avinainder; Collins, Bradley L; Gupta, Ankur et al. (2018) Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry. J Am Coll Cardiol 71:292-302
Bajaj, Navkaranbir S; Gutiérrez, Orlando M; Arora, Garima et al. (2018) Racial Differences in Plasma Levels of N-Terminal Pro-B-Type Natriuretic Peptide and Outcomes: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. JAMA Cardiol 3:11-17
Alvi, Raza M; Neilan, Anne M; Tariq, Noor et al. (2018) Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure. J Am Coll Cardiol 72:518-530
Bajaj, Navkaranbir S; Patel, Nirav; Kalra, Rajat et al. (2018) Neurological effects of proprotein convertase subtilisin/kexin type 9 inhibitors: direct comparisons. Eur Heart J Qual Care Clin Outcomes 4:132-141
Abou Ziki, M D; Seidelmann, S B; Smith, E et al. (2018) Deleterious protein-altering mutations in the SCN10A voltage-gated sodium channel gene are associated with prolonged QT. Clin Genet 93:741-751
Fujikura, Kana; Golive, Anjani D; Ando, Tomo et al. (2018) Increased Iron Deposition Is Directly Associated With Myocardial Dysfunction in Patients With Sickle Cell Disease. JACC Cardiovasc Imaging 11:279-280

Showing the most recent 10 out of 132 publications